These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 17069854)
1. Crystal structure of scytalidoglutamic peptidase with its first potent inhibitor provides insights into substrate specificity and catalysis. Pillai B; Cherney MM; Hiraga K; Takada K; Oda K; James MN J Mol Biol; 2007 Jan; 365(2):343-61. PubMed ID: 17069854 [TBL] [Abstract][Full Text] [Related]
2. Catalytic residues and substrate specificity of scytalidoglutamic peptidase, the first member of the eqolisin in family (G1) of peptidases. Kataoka Y; Takada K; Oyama H; Tsunemi M; James MN; Oda K FEBS Lett; 2005 Jun; 579(14):2991-4. PubMed ID: 15907842 [TBL] [Abstract][Full Text] [Related]
3. The molecular structure and catalytic mechanism of a novel carboxyl peptidase from Scytalidium lignicolum. Fujinaga M; Cherney MM; Oyama H; Oda K; James MN Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3364-9. PubMed ID: 14993599 [TBL] [Abstract][Full Text] [Related]
4. The peptidases from fungi and viruses. James MN Biol Chem; 2006 Aug; 387(8):1023-9. PubMed ID: 16895471 [TBL] [Abstract][Full Text] [Related]
5. Studies on the catalytic mechanism of a glutamic peptidase. Kondo MY; Okamoto DN; Santos JA; Juliano MA; Oda K; Pillai B; James MN; Juliano L; Gouvea IE J Biol Chem; 2010 Jul; 285(28):21437-45. PubMed ID: 20442413 [TBL] [Abstract][Full Text] [Related]
6. The structure of endothiapepsin complexed with a Phe-Tyr reduced-bond inhibitor at 1.35 Å resolution. Guo J; Cooper JB; Wood SP Acta Crystallogr F Struct Biol Commun; 2014 Jan; 70(Pt 1):30-3. PubMed ID: 24419612 [TBL] [Abstract][Full Text] [Related]
7. Identification of a glutamine residue essential for catalytic activity of aspergilloglutamic peptidase by site-directed mutagenesis. Yabuki Y; Kubota K; Kojima M; Inoue H; Takahashi K FEBS Lett; 2004 Jul; 569(1-3):161-4. PubMed ID: 15225626 [TBL] [Abstract][Full Text] [Related]
8. X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution. Veerapandian B; Cooper JB; Sali A; Blundell TL J Mol Biol; 1990 Dec; 216(4):1017-29. PubMed ID: 2266553 [TBL] [Abstract][Full Text] [Related]
9. Structure of signal peptide peptidase A with C-termini bound in the active sites: insights into specificity, self-processing, and regulation. Nam SE; Paetzel M Biochemistry; 2013 Dec; 52(49):8811-22. PubMed ID: 24228759 [TBL] [Abstract][Full Text] [Related]
10. Structural and kinetic contributions of the oxyanion binding site to the catalytic activity of acylaminoacyl peptidase. Kiss AL; Palló A; Náray-Szabó G; Harmat V; Polgár L J Struct Biol; 2008 May; 162(2):312-23. PubMed ID: 18325786 [TBL] [Abstract][Full Text] [Related]
11. Structural basis for the substrate specificity of a Bacillus 1,3-1,4-beta-glucanase. Gaiser OJ; Piotukh K; Ponnuswamy MN; Planas A; Borriss R; Heinemann U J Mol Biol; 2006 Apr; 357(4):1211-25. PubMed ID: 16483609 [TBL] [Abstract][Full Text] [Related]
12. The acylaminoacyl peptidase from Aeropyrum pernix K1 thought to be an exopeptidase displays endopeptidase activity. Kiss AL; Hornung B; Rádi K; Gengeliczki Z; Sztáray B; Juhász T; Szeltner Z; Harmat V; Polgár L J Mol Biol; 2007 Apr; 368(2):509-20. PubMed ID: 17350041 [TBL] [Abstract][Full Text] [Related]
13. Crystal structures of penicillin acylase enzyme-substrate complexes: structural insights into the catalytic mechanism. McVey CE; Walsh MA; Dodson GG; Wilson KS; Brannigan JA J Mol Biol; 2001 Oct; 313(1):139-50. PubMed ID: 11601852 [TBL] [Abstract][Full Text] [Related]
14. Crystal structures of Aspergillus oryzae aspartic proteinase and its complex with an inhibitor pepstatin at 1.9A resolution. Kamitori S; Ohtaki A; Ino H; Takeuchi M J Mol Biol; 2003 Mar; 326(5):1503-11. PubMed ID: 12595261 [TBL] [Abstract][Full Text] [Related]
15. Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases. Veerapandian B; Cooper JB; Sali A; Blundell TL; Rosati RL; Dominy BW; Damon DB; Hoover DJ Protein Sci; 1992 Mar; 1(3):322-8. PubMed ID: 1304340 [TBL] [Abstract][Full Text] [Related]
16. Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor. Laco GS; Schalk-Hihi C; Lubkowski J; Morris G; Zdanov A; Olson A; Elder JH; Wlodawer A; Gustchina A Biochemistry; 1997 Sep; 36(35):10696-708. PubMed ID: 9271500 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor. Nar H; Werle K; Bauer MM; Dollinger H; Jung B J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin. Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718 [TBL] [Abstract][Full Text] [Related]
19. Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters. Bone R; Sampson NS; Bartlett PA; Agard DA Biochemistry; 1991 Feb; 30(8):2263-72. PubMed ID: 1998685 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure of carboxylesterase from Pseudomonas fluorescens, an alpha/beta hydrolase with broad substrate specificity. Kim KK; Song HK; Shin DH; Hwang KY; Choe S; Yoo OJ; Suh SW Structure; 1997 Dec; 5(12):1571-84. PubMed ID: 9438866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]